As a dual JAK1 and JAK2 inhibitor, this medicine has the potential to modulate signal transduction from a variety of cytokines implicated in the pathogenesis of psoriasis, including interleukin IL12 and IL23 (135, 136). This evidence concerns the gene JAK1 and psoriasis.